Concepedia

Zero-order Intravenous Input

Zero-Order Intravenous Input is an intravenous dosing model in which a constant rate of drug administration is maintained over time, distinguished from other input models by its independence from drug concentration and absence of rate variation during infusion.

12

Publications

441

Citations

50

Authors

23

Institutions

Publications per year

2017–2026

1

Variants

Zero-order Iv Input

Parents

Publications

12

Population Pharmacokinetics of Tigecycline in Patients with Complicated Intra-Abdominal or Skin and Skin Structure Infections

Scott A. Van Wart, Joel Owen, Elizabeth Ludwig et al. · Antimicrobial Agents and Chemotherapy · 2006 · 68 citations · Full text

, , +13

General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy

D P Vaughan, Geoffrey T. Tucker · European Journal of Clinical Pharmacology · 1976 · 49 citations

, , +15

Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients

Partha Nandy, Mahesh N. Samtani, Rachel Lin · Antimicrobial Agents and Chemotherapy · 2010 · 46 citations · Full text

, , +17

Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients

Tôru Ishibashi, Yoshitaka Yano, Takayoshi Oguma · British Journal of Clinical Pharmacology · 2003 · 44 citations · Full text

, , +17

Pharmacokinetics of remifentanil in conscious cats and cats anesthetized with isoflurane

Bruno H. Pypendop, Robert J. Brosnan, Kristine T. Siao et al. · American Journal of Veterinary Research · 2008 · 39 citations · Full text

, , +14

1–5 of 12

Authors

50

  1. JO
    Joel Owen

    Cognizant (United States), United States

    2 publications · 102 citations

    2

    h-index

  2. JK
    Joan Korth‐Bradley

    Pfizer (United States), United States

    2 publications · 106 citations

    2

    h-index

  3. CM
    Christopher M. Rubino

    Institute for Clinical Pharmacodynamics (United States), United States

    2 publications · 73 citations

    2

    h-index

  4. DW
    David Williams

    University of Michigan, United States

    1 publications · 13 citations

    1

    h-index

  5. PN
    Partha Nandy

    Janssen (United States), United States

    1 publications · 46 citations

    1

    h-index

1–5 of 50

Institutions

23

  1. Institute for Clinical Pharmacodynamics (United States)

    Schenectady, United States

    2 h-index

    6 publications

    222 citations

  2. Cognizant (United States)

    Teaneck, United States

    2 h-index

    7 publications

    408 citations

  3. Cytokinetics (United States)

    South San Francisco, United States

    1 h-index

    1 publications

    22 citations

  4. Wellcome Trust

    London, United Kingdom

    1 h-index

    1 publications

    27 citations

  5. University of Illinois Chicago

    Chicago, United States

    1 h-index

    1 publications

    38 citations

  6. University of Sheffield

    Sheffield, United Kingdom

    1 h-index

    2 publications

    98 citations

  7. Union University

    Jackson, United States

    1 h-index

    1 publications

    34 citations

  8. Albany College of Pharmacy and Health Sciences

    Albany, United States

    1 h-index

    1 publications

    34 citations

1–8 of 23

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 4 publications · 187 citations

    4

    h-index

  2. British Journal of Clinical Pharmacology

    BJCP · 2 publications · 71 citations

    2

    h-index

  3. American Journal of Veterinary Research

    AJVR · 1 publications · 39 citations

    1

    h-index

  4. European Journal of Clinical Pharmacology

    1 publications · 49 citations

    1

    h-index

  5. Biopharmaceutics & Drug Disposition

    1 publications · 26 citations

    1

    h-index

1–5